MDGL MADRIGAL PHARMACEUTICALS, INC.
Nasdaq · SEC CIK 1157601 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $81.48M 28 sales by 9 insiders
- Filings on record
- 169 since 2021-08-04, latest 2026-09-11 16:57
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| FRIEDMAN PAUL A | Dir | — | $26.66M |
| Taub Rebecca | Dir | — | $21.68M |
| Sibold William John | Pres, CEO, Dir | — | $10.48M |
| BATE KENNETH | Dir | — | $8.03M |
| Levy Richard S | Dir | — | $7.36M |
| Dier Mardi | EVP, CFO | — | $3.77M |
| Huntsman Carole | Chief Commercial Off | — | $1.71M |
| Soergel David | Chief Medical Off | — | $952.0K |
| Kelley Shannon T | GC | — | $841.6K |
| Thakkar Rita | CAO | — | — |
Transactions 205
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-12-28 | 2022-12-23 | MDGL | Sukhija Remy | Chief Commercial Off | S - Sale+OE | $274.14 | -30.0K | 9,734 | -76% | -$8.22M |
| D | 2022-12-28 | 2022-12-23 | MDGL | Sukhija Remy | Chief Commercial Off | M - OptEx | $60.26 | +30.0K | 30.0K | New | +$1.81M |
| 2021-12-07 | 2021-12-03 | MDGL | BAY CITY CAPITAL LLC | 10% | J - Other | $0.00 | -24.2K | 1,261 | -95% | $0 | |
| MI | 2021-12-07 | 2021-12-03 | MDGL | BAY CITY CAPITAL LLC | 10% | J - Other | $0.00 | -800.0K | 0 | -100% | $0 |
| MI | 2021-12-07 | 2021-12-03 | MDGL | CRAVES FRED B | Dir, 10% | J - Other | $0.00 | -824.2K | 1.51M | -35% | $0 |
Purchase Sale Sale after option exercise All abbreviations